143 related articles for article (PubMed ID: 7967709)
21. The effect of ethyldeshydroxy-sparsomycin and cisplatin on the intracellular glutathione level and glutathione S-transferase activity.
Hofs HP; Wagener TD; de Valk-Bakker V; van Rennes H; Doesburg WH; Ottenheijm HC; de Grip WJ
Anticancer Drugs; 1997 Apr; 8(4):349-57. PubMed ID: 9180388
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of poly(adenosine diphosphate-ribose) polymerase by thymidine and thymidine analogues in L1210 cells and its relationship to the potentiation of the antitumor activity of 1,3-bis(2-chloroethyl)-1-nitrosourea but not of 3'-[3-(2-chloroethyl)-3-nitrosoureido]-3'-deoxythymidine.
August EM; Cooper DL; Prusoff WH
Cancer Res; 1991 Mar; 51(6):1586-90. PubMed ID: 1900213
[TBL] [Abstract][Full Text] [Related]
23. The polymorphic human glutathione transferase T1-1, the most efficient glutathione transferase in the denitrosation and inactivation of the anticancer drug 1,3-bis(2-chloroethyl)-1-nitrosourea.
Lien S; Larsson AK; Mannervik B
Biochem Pharmacol; 2002 Jan; 63(2):191-7. PubMed ID: 11841793
[TBL] [Abstract][Full Text] [Related]
24. Brostallicin, a novel anticancer agent whose activity is enhanced upon binding to glutathione.
Geroni C; Marchini S; Cozzi P; Galliera E; Ragg E; Colombo T; Battaglia R; Howard M; D'Incalci M; Broggini M
Cancer Res; 2002 Apr; 62(8):2332-6. PubMed ID: 11956092
[TBL] [Abstract][Full Text] [Related]
25. In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines.
Mulcahy RT; Siemann DW
Cancer Res; 1983 Oct; 43(10):4709-13. PubMed ID: 6883329
[TBL] [Abstract][Full Text] [Related]
26. O6-methylguanine as a modulator of antitumor activity of N-alkyl-N-nitrosoureas in vivo.
Gorbacheva LB; Kukushkina GV; Elksne SJ; Miniker TD; Melnik SYa ; Preobrazhenskaya MN
Anticancer Drugs; 1991 Apr; 2(2):185-9. PubMed ID: 1958863
[TBL] [Abstract][Full Text] [Related]
27. The role of isocyanates in the toxicity of antitumour haloalkylnitrosoureas.
Gibson NW; Hickman JA
Biochem Pharmacol; 1982 Sep; 31(17):2795-800. PubMed ID: 7138575
[TBL] [Abstract][Full Text] [Related]
28. Characterization of the inhibition of glutathione reductase and the recovery of enzyme activity in exponentially growing murine leukemia (L1210) cells treated with 1,3-bis(2-chloroethyl)-1-nitrosourea.
Cohen MB; Duvel DL
Biochem Pharmacol; 1988 Sep; 37(17):3317-20. PubMed ID: 3401259
[TBL] [Abstract][Full Text] [Related]
29. O6-methylguanine and temozolomide can reverse the resistance to chloroethylnitrosoureas of a mouse L1210 leukemia.
D'Incalci M; Taverna P; Erba E; Filippeschi S; Potenza D; Mariani L; Citti L; Catapano CV
Anticancer Res; 1991; 11(1):115-21. PubMed ID: 2018345
[TBL] [Abstract][Full Text] [Related]
30. Benzene metabolism by reconstituted cytochromes P450 2B1 and 2E1 and its modulation by cytochrome b5, microsomal epoxide hydrolase, and glutathione transferases: evidence for an important role of microsomal epoxide hydrolase in the formation of hydroquinone.
Snyder R; Chepiga T; Yang CS; Thomas H; Platt K; Oesch F
Toxicol Appl Pharmacol; 1993 Oct; 122(2):172-81. PubMed ID: 8211999
[TBL] [Abstract][Full Text] [Related]
31. Differential inhibition of cellular glutathione reductase activity by isocyanates generated from the antitumor prodrugs Cloretazine and BCNU.
Rice KP; Penketh PG; Shyam K; Sartorelli AC
Biochem Pharmacol; 2005 May; 69(10):1463-72. PubMed ID: 15857610
[TBL] [Abstract][Full Text] [Related]
32. Effect of thymidine on uptake, DNA alkylation, and DNA repair in L1210 cells treated with 1,3-bis(2-chloroethyl)-1-nitrosourea or 3'-[3-(2-chloroethyl)-3-nitrosoureido]-3'-deoxythymidine.
August EM; Prusoff WH
Cancer Res; 1988 Aug; 48(15):4272-5. PubMed ID: 3390823
[TBL] [Abstract][Full Text] [Related]
33. Characterization of distinct forms of cytochromes P-450, epoxide metabolizing enzymes and UDP-glucuronosyltransferases in rat skin.
Pham MA; Magdalou J; Totis M; Fournel-Gigleux S; Siest G; Hammock BD
Biochem Pharmacol; 1989 Jul; 38(13):2187-94. PubMed ID: 2500129
[TBL] [Abstract][Full Text] [Related]
34. Studies with 2,5-piperazinedione, 3,6-bis(5-chloro-2-piperidyl)-,dihydrochloride. III. Biochemical and therapeutic effects in L1210 leukemias sensitive and resistant to alkylating agents: comparison with melphalan, cyclophosphamide, and BCNU.
Schabel FM; Trader MW; Laster WR; Shaddix SC; Brockman RW
Cancer Treat Rep; 1976 Sep; 60(9):1325-33. PubMed ID: 1016968
[TBL] [Abstract][Full Text] [Related]
35. The effects of dietary ellagic acid on rat hepatic and esophageal mucosal cytochromes P450 and phase II enzymes.
Ahn D; Putt D; Kresty L; Stoner GD; Fromm D; Hollenberg PF
Carcinogenesis; 1996 Apr; 17(4):821-8. PubMed ID: 8625497
[TBL] [Abstract][Full Text] [Related]
36. [The expression of GST pi mRNA in the P388/ADR and L1210/DDP resistant lines examined by synthetic probe].
Liu YB
Zhonghua Zhong Liu Za Zhi; 1993 Jul; 15(4):264-7. PubMed ID: 8174463
[TBL] [Abstract][Full Text] [Related]
37. Response of drug-sensitive and -resistant L1210 leukemias to high-dose chemotherapy.
Griswold DP; Trader MW; Frei E; Peters WP; Wolpert MK; Laster WR
Cancer Res; 1987 May; 47(9):2323-7. PubMed ID: 3567926
[TBL] [Abstract][Full Text] [Related]
38. Decreased DNA interstrand cross-linking and cytotoxicity induced in human brain tumor cells by 1,3-bis(2-chloroethyl)-1-nitrosourea after in vitro reaction with glutathione.
Ali-Osman F; Caughlan J; Gray GS
Cancer Res; 1989 Nov; 49(21):5954-8. PubMed ID: 2551496
[TBL] [Abstract][Full Text] [Related]
39. Comparative effects of butylated hydroxyanisole on hepatic in vivo DNA binding and in vitro biotransformation of aflatoxin B1 in the rat and mouse.
Monroe DH; Eaton DL
Toxicol Appl Pharmacol; 1987 Sep; 90(3):401-9. PubMed ID: 3116723
[TBL] [Abstract][Full Text] [Related]
40. The significance of free radicals and free radical scavengers in L1210 leukemia.
Brown AC; Lutton JD
Adv Exp Med Biol; 1988; 241():135-48. PubMed ID: 3223404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
